Inovio Pharmaceuticals
INO
INO
218 hedge funds and large institutions have $693M invested in Inovio Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 88 increasing their positions, 51 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
218
Holders Change
-9
Holders Change %
-3.96%
% of All Funds
3.84%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
39
Increased
88
Reduced
51
Closed
45
Calls
$38.4M
Puts
$44M
Net Calls
-$5.6M
Net Calls Change
+$3M
Top Buyers
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$37.2M |
| 2 |
BlackRock
New York
|
+$30.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21.4M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.39M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$7.28M |
Top Sellers
| 1 |
Man Group
London,
United Kingdom
|
-$7.06M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$6.94M |
| 3 |
State Street
Boston,
Massachusetts
|
-$5.93M |
| 4 |
JG
Jefferies Group
New York
|
-$4.43M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$4.21M |
